CLINDAMYCIN BNM clindamycin (as hydrochloride) 150 mg capsule blister pack

Țară: Australia

Limbă: engleză

Sursă: Department of Health (Therapeutic Goods Administration)

Ingredient activ:

clindamycin hydrochloride, Quantity: 162.87 mg (Equivalent: clindamycin, Qty 150 mg)

Disponibil de la:

Boucher & Muir Pty Ltd

INN (nume internaţional):

clindamycin hydrochloride

Forma farmaceutică:

Capsule, hard

Compoziție:

Excipient Ingredients: lactose monohydrate; magnesium stearate; maize starch; purified talc; titanium dioxide; indigo carmine; sorbitan monolaurate; Gelatin; sodium lauryl sulfate; carmoisine; patent blue V

Calea de administrare:

Oral

Unități în pachet:

100 capsules, 24 capsules

Tip de prescriptie medicala:

(S4) Prescription Only Medicine

Indicații terapeutice:

Clindamycin BNM (clindamycin hydrochloride) capsules are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.,Clindamycin BNM capsules are also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. ,Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgement of the physician, a penicillin is inappropriate. ,Anaerobes Serious respiratory tract infections such as empyema, anaerobic pneumonitis and lung abscess; serious skin and skin structure infections; septicaemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, non-gonococcal tubo-ovarian abscess, pelvic cellulitis and post-surgical vaginal cuff infection. ,Streptococci Serious respiratory tract infections; serious skin and skin structure infections, septicaemia. ,Staphylococci Serious respiratory tract infections; serious skin and skin structure infections; septicaemia; acute haematogenous osteomyelitis. ,Pneumococci Serious respiratory tract infections. ,Adjunctive therapy In the surgical treatment of chronic bone and joint infections due to susceptible organisms. Indicated surgical procedures should be performed in conjunction with antibiotic therapy. ,Bacteriological studies should be performed to determine the causative organisms and their susceptibility to clindamycin.

Rezumat produs:

Visual Identification: Hard gelatin capsule with purple transparent body and powder blue opaque cap containing a white/off white powder; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Statutul autorizaţiei:

Licence status A

Data de autorizare:

2015-03-20

Prospect

1
CLINDAMYCIN BNM
Consumer Medicine Information
CLINDAMYCIN BNM
_CLINDAMYCIN (AS HYDROCHLORIDE) _
Capsules 150 mg
WHAT IS IN THIS LEAFLET
Please read this leaflet carefully before you start taking Clindamycin
BNM.
This leaflet answers some common questions about Clindamycin BNM. It
does not
contain
all
the
available
information.
The
most
up-to-date
Consumer
Medicine
Information can be downloaded from www.ebs.tga.gov.au.
Reading this leaflet does not take the place of talking to your doctor
or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the
risks of you taking
Clindamycin BNM against the benefits this medicine is expected to have
for you.
IF
YOU
HAVE
ANY
CONCERNS
ABOUT
TAKING
THIS
MEDICINE,
ASK
YOUR
DOCTOR
OR
PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may want to read it again.
WHAT CLINDAMYCIN BNM IS USED FOR
Clindamycin BNM contains clindamycin, an antibiotic. Clindamycin is
used to treat
bacterial infections in different parts of the body.
It works by killing or stopping the growth of the bacteria causing
your infection.
Clindamycin BNM will not work against viral infections such as colds
or flu.
Clindamycin BNM is recommended for patients who are allergic to
penicillin or patients
for whom penicillin is not suitable.
Your doctor may have prescribed this medicine for another reason.
ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY IT HAS BEEN
PRESCRIBED FOR
YOU.
Clindamycin BNM is available only with a doctor's prescription.
Clindamycin BNM is not addictive.
2
CLINDAMYCIN BNM
BEFORE YOU TAKE CLINDAMYCIN BNM
_ _
Clindamycin BNM is not suitable for everyone.
_ _
_WHEN YOU MUST NOT TAKE IT _
DO NOT TAKE CLINDAMYCIN BNM IF YOU ARE ALLERGIC TO ANY MEDICINE
CONTAINING
CLINDAMYCIN, LINCOMYCIN (A VERY SIMILAR ANTIBIOTIC), OR ANY OF THE
INGREDIENTS LISTED
AT THE END OF THIS LEAFLET.
DO NOT TAKE IT AFTER THE EXPIRY DATE (‘EXP’) PRINTED ON THE PACK.
If you take it after the expiry date has passed, it may not work as
well.
DO NOT TAKE IT IF THE PACKAGING IS TORN OR SHOWS SIGN

Caracteristicilor produsului

CLINDAMYCIN BNM
1
AUSTRALIAN PRODUCT INFORMATION
CLINDAMYCIN BNM
(CLINDAMYCIN HYDROCHLORIDE)
HARD CAPSULE
1
NAME OF THE MEDICINE
Clindamycin hydrochloride
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Clindamycin BNM capsules contain clindamycin hydrochloride, equivalent
to 150 mg of
clindamycin.
Excipients with known effect: lactose monohydrate
For the full list of excipients, see Section 6.1 List of excipients.
3
PHARMACEUTICAL FORM
Capsules.
The capsules have a powder blue opaque cap and a purple transparent
body.
4
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Clindamycin BNM (clindamycin hydrochloride) capsules are indicated in
the treatment of
serious infections caused by susceptible anaerobic bacteria.
Clindamycin BNM capsules are also indicated in the treatment of
serious infections due to
susceptible strains of
_streptococci_
,
_pneumococci _
and
_staphylococci_
.
Its use should be reserved for penicillin-allergic patients or other
patients for whom, in the
judgement of the physician, a penicillin is inappropriate.
ANAEROBES
Serious respiratory tract infections such as empyema, anaerobic
pneumonitis and lung
abscess; serious skin and skin structure infections; septicaemia;
intra-abdominal infections
such
as
peritonitis
and
intra-abdominal
abscess
(typically
resulting
from
anaerobic
organisms resident in the normal gastrointestinal tract); infections
of the female pelvis and
genital tract such as endometritis, non-gonococcal tubo-ovarian
abscess, pelvic cellulitis and
post-surgical vaginal cuff infection.
CLINDAMYCIN BNM
2
STREPTOCOCCI
Serious respiratory tract infections; serious skin and skin structure
infections, septicaemia.
STAPHYLOCOCCI
Serious respiratory tract infections; serious skin and skin structure
infections; septicaemia;
acute haematogenous osteomyelitis.
PNEUMOCOCCI
Serious respiratory tract infections.
ADJUNCTIVE THERAPY
In the surgical treatment of chronic bone and joint infections due to
susceptible organisms.
Indicated surgical procedures should be performed in conjunction with
antibio